weight / management
LOT / AX-K-40
§ Product monograph
RETAKLIK 40mg
40mg · single-vial research unit
Triple-agonist metabolic pen supporting appetite control, glucose regulation and energy expenditure.
Active
Retatrutide
Dosage / vial
40mg
Purity
99.278%
Batch
002/26
£329.00
per vial · excl. shipping
Mechanism
Extended-titration tirzepatide analog for sustained receptor engagement in longitudinal studies.
Metabolic enhancement
Weight support
Better glucose control
1
For research use only. Not for human consumption. Analytical report on file.
§ Referenced studies
The evidence
Study index is being updated. Contact us for a full research bibliography for RETAKLIK 40mg.